Moreover, MITD1 deficiency has been discovered to hinder the growth and migration of clear cell renal cell carcinoma by inducing ferroptosis through the TAZ/SLC7A11 pathway [23]. Here, SLC7A11 is linked to clear cell renal carcinoma.